Medicine recalls
|
| |
| DH endorses recall of 4 batches of Sodium Chloride Injection 23.4% w/v 30ml vial |
| |
The Department of Health (DH) today (July 8) endorsed the licensed drug wholesaler, Sino-Asia Pharmaceutical Supplies Ltd. (Sino-Asia), to recall four batches of Sodium Chloride Injection 23.4% w/v (Registration no.: HK-63077) (batch no.: 4D603, 4F660, 5A864, 5C921) from the market because of a potential quality issue.
The DH received notifications from Sino-Asia that the product's Canada manufacturer is recalling the above batches of product as precautionary measure because 3 other batches of the product were found out-of-specification (OOS) result for the pH value. The 3 problematic batches have not been imported in Hong Kong. DH's investigation is continuing.
The above product containing sodium chloride is an over-the-counter medicine used for management of deficiencies of sodium and chloride ions in salt-losing conditions.
According to Sino-Asia, a total of 5680 vials of the product have been supplied to Hospital Authority hospitals and one private doctor. Sino-Asia has already notified the hospitals and the doctor involved.
So far, the DH has not received any adverse reaction reports in connection with these batches of product. The DH will closely monitor the recall.
|
| |
|
|
